MedPath

International Retrospective Cohort Study of Conversion Therapy (Adjuvant surgery) for Stage IV Gastric Cancer 1

Not Applicable
Conditions
StageIV gastric cancer
Registration Number
JPRN-UMIN000022321
Lead Sponsor
FACO(Federation of Asian Clinical Oncology)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
900
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of operative complications after conversion therapy
Secondary Outcome Measures
NameTimeMethod
Overall Survival(OS), Relapse free survival(RFS), Response rate, and Histological response
© Copyright 2025. All Rights Reserved by MedPath